Ghent University: Neurotransmitter Discovery

New Discovery: Neurotransmitter Imbalance in the Insula

Recent research from Ghent University (Belgium) has identified a critical imbalance in the brains of fibromyalgia patients. Using advanced MRS (Magnetic Resonance Spectroscopy), researchers found an abnormal ratio between two key neurotransmitters: Glutamate and GABA.

The Excitatory vs. Inhibitory Balance

• Glutamate: The "accelerator" of the brain (excitatory). High levels increase pain sensitivity.
• GABA: The "brakes" of the brain (inhibitory). Low levels mean the brain cannot properly dampen pain signals.

The study found that in the Insula — a brain region central to processing pain and emotions — the "brakes" are effectively failing while the "accelerator" is pushed down. This provides a clear biological explanation for why patients experience widespread pain from stimuli that others would not find painful.

Future Implications

This discovery moves fibromyalgia further away from being a "mysterious" condition and toward a measurable neurological disorder. It opens doors for new treatments specifically designed to restore this GABA/Glutamate balance, potentially through targeted medication or neuromodulation.